GlassScriptPhysician profile
Elena Model-Rybakova
NPI 1891802815
$805.01
in general payments reported to CMS, 2019-2025
13 companies · $149 in 2025
The $149 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $444 · 2020: $35.75 · 2022: $107 · 2023: $50.19 · 2024: $18.96 · 2025: $149.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $218.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $217.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $306.12 | 2019 | |
| Corium, LLC | $149.45 | 2022-2025 | Azstarys |
| Neos Therapeutics, LP | $64.97 | 2019-2020 | |
| Glaxosmithkline, LLC. | $57.57 | 2019-2025 | Bexsero, Rotarix, Pediarix |
| Tris Pharma INC | $45.04 | 2019-2020 | |
| Cranial Technologies, INC | $34.48 | 2024-2025 | Doc Band |
| Alk-Abello, INC | $32.47 | 2025 | Odactra, Ragwitek, Grastek |
| Verrica Pharmaceuticals INC. | $23.33 | 2025 | Ycanth |
| Nestle Healthcare Nutrition INC. | $22.46 | 2023 | |
| Novartis Pharmaceuticals Corporation | $21.11 | 2019 | |
| Vertical Pharmaceuticals, LLC | $18.68 | 2025 | Relexxii |
| Merck Sharp & Dohme LLC | $18.08 | 2019 | |
| Rhodes Pharmaceuticals L.P. | $11.25 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elena Model-Rybakova listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.